Patents by Inventor Ho-Yuan Chou

Ho-Yuan Chou has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Composition for preventing or treating infection
    Patent number: 11253581
    Abstract: The present disclosure relates to a composition for preventing and treating Mycoplasma synoviae infection, the composition comprising Tuf, NOX, MS53-0285 or a combination thereof as active ingredients. The composition of the present disclosure is effective in alleviating symptoms caused by Mycoplasma synoviae infection and can be used as an effective tool in preventing or treating poultry diseases.
    Type: Grant
    Filed: November 1, 2017
    Date of Patent: February 22, 2022
    Assignee: AGRICULTURAL TECHNOLOGY RESEARCH INSTITUTE
    Inventors: Jiunn-Horng Lin, Ho-Yuan Chou, Jyh-Perng Wang, Zeng-Weng Chen, Weng-Zeng Huang, Hsiu-Hui Wu, Hui-Jie Lin, Sheng-Xiang Huang
  • COMPOSITION FOR PREVENTING OR TREATING MYCOPLASMA SYNOVIAE INFECTION
    Publication number: 20210322530
    Abstract: The present disclosure relates to a composition for preventing and treating Mycoplasma synoviae infection, the composition comprising Tuf, NOX, MS53-0285 or a combination thereof as active ingredients. The composition of the present disclosure is effective in alleviating symptoms caused by Mycoplasma synoviae infection and can be used as an effective tool in preventing or treating poultry diseases.
    Type: Application
    Filed: November 1, 2017
    Publication date: October 21, 2021
    Applicant: AGRICULTURAL TECHNOLOGY RESEARCH INSTITUTE
    Inventors: Jiunn-Horng LIN, Ho-Yuan CHOU, Jyh-Perng WANG, Zeng-Weng CHEN, Weng-Zeng HUANG, Hsiu-Hui WU, Hui-Jie LIN, Sheng-Xiang HUANG
  • THERMOSENSITIVE HEPATITIS B VACCINE
    Publication number: 20120045511
    Abstract: A thermosensitive hepatitis B vaccine is provided. The thermosensitive hepatitis B vaccine includes an aqueous phase solution comprising a biodegradable thermosensitive hydrogel copolymer; a surface antigen of hepatitis B virus (HBsAg); and a bioactive substance. The thermosensitive hepatitis B vaccine of the disclosure is particularly suitable for being applied in the patients, which are low responsive or non-responsive to conventional hepatitis B vaccine, for enhancing the induction of cell-mediated immune responses and overcoming the HBsAg non-responsiveness.
    Type: Application
    Filed: August 17, 2010
    Publication date: February 23, 2012
    Applicant: INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE
    Inventors: Mi-Hua Tao, Ho-Yuan Chou, Hsin-Hsin Shen, Tsai-Yu Lin